Regional Anaesthesia in Intensive Care Unit

NCT05131633 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-02-17

No results posted yet for this study

Summary

Pain is a major problem in Intensive Care Unit (ICU). Adequate pain management not only means decreasing the pain intensity, but also improving the functionality and allowing the early mobilization that is a prerequisite for improving recovery and decreasing the risk of complications in ICU. The complex problems involved in pain, analgesic interventions, and outcome have been emphasized in several surveys over the past decades, but apparently with only small improvements, despite the existence of several guidelines for perioperative pain management.

Regional analgesia techniques (peripheral and neuraxial nerve blocks) have the potential to decrease the physiological stress response to trauma or surgery, reducing the possibility of surgical complications and improving the outcomes. Recent studies suggested that surgical and trauma ICU patients receive opioid-hypnotics continuous infusions to prevent pain and agitation that could increase the risk of posttraumatic stress disorder and chronic neuropathic pain symptoms, and chronic opioid use. Also they may reduce the total amount of opioid analgesics necessary to achieve adequate pain control and the development of potentially dangerous side effects. The use of the regional anesthesia technique in the ICU, however, can, in part, be limited by the presence of hemodynamic instability, bleeding diathesis, and by the fear of the performing procedures potentially associated with significant side effects in heavily sedated patients.

Although regional anesthesia emerges as a new and very interesting player for pain management in ICU, today very few data exists about the use of RA (including PNB and neuraxial nerves blocks) by the practicians in ICU/stepdown units. The main objective of this study is to assess the use of RA for pain management both initiates in the operative room for surgical patients then transferred in ICU/stepdown units and performs directly by the practicians in ICU/stepdown units, in several french units.

Conditions

  • Intensive Care Unit

Sponsors & Collaborators

  • Hôpital Edouard Herriot

    collaborator OTHER
  • Rangueil Hospital

    collaborator OTHER
  • Hospices Civils de Lyon

    collaborator OTHER
  • Hopital Louis Pradel

    collaborator OTHER
  • Hôpital Saint Camille

    collaborator UNKNOWN
  • Hôpital de la Timone

    collaborator OTHER
  • University Hospital, Grenoble

    collaborator OTHER
  • University Hospital, Lille

    collaborator OTHER
  • Saint Antoine University Hospital

    collaborator OTHER
  • University Hospital, Strasbourg

    collaborator OTHER
  • University Hospital, Marseille

    collaborator OTHER
  • Centre Hospitalier Universitaire de Nīmes

    collaborator OTHER
  • CH Aix

    collaborator UNKNOWN
  • CH Martigues

    collaborator UNKNOWN
  • CH Alberville

    collaborator UNKNOWN
  • CH Chambery

    collaborator UNKNOWN
  • Rennes University Hospital

    collaborator OTHER
  • Bichat Hospital

    collaborator OTHER
  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-18
Primary Completion
2021-11-20
Completion
2021-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05131633 on ClinicalTrials.gov